ACAD stock

Acadia Pharmaceuticals Inc [ACAD] stock Upgrade by Deutsche Bank analyst, price target now $35
Brandon Evans
Acadia Pharmaceuticals Inc [NASDAQ: ACAD] slipped around -2.34 points on Wednesday, while shares priced at $21.26 at the close of ...